All sponsors

JCR Pharmaceuticals Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS7
PHASE 3 / 2-33
RECRUITING1
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO67%

Delay Index: of 6 active trials registered more than a year ago, 4 have moved their primary completion (readout) date by more than 6 months since first registration (median +43.0 months). See all sponsors →

Open JCR Pharmaceuticals Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
JR-141
NCT03708965
P2Active, not recruitingMucopolysaccharidosis II192026-12-31 (+67 mo)
JR-141
NCT04573023
P3Active, not recruitingMucopolysaccharidosis II862027-10-31 (+43 mo)
JR-141
NCT05594992
P3Enrolling by invitationMucopolysaccharidosis II802028-02-28
JR-446
NCT07640984
P1/2RecruitingMucopolysaccharidosis IIIB122028-06-30
JR-441
NCT06095388
P1/2Active, not recruitingMucopolysaccharidosis III-A152029-10-31
JR-141
NCT04348136
P2/3Active, not recruitingMucopolysaccharidosis II272030-03-31 (+105 mo)
JR-446
NCT06488924
P1/2Active, not recruitingMucopolysaccharidosis III-B102030-04-30 (+37 mo)